516 related articles for article (PubMed ID: 17222331)
1. Lymphatic vessels assessment in feline mammary tumours.
Sarli G; Sassi F; Brunetti B; Rizzo A; Diracca L; Benazzi C
BMC Cancer; 2007 Jan; 7():7. PubMed ID: 17222331
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of VEGF-C/VEGFR-3 system and lymphatic vessel extent in normal and adenomatous human pituitary tissues.
Onofri C; Losa M; Uhl E; Stalla GK; Renner U
Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):152-7. PubMed ID: 18205092
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
4. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.
Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J
Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866
[TBL] [Abstract][Full Text] [Related]
6. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
[TBL] [Abstract][Full Text] [Related]
7. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA
Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020
[TBL] [Abstract][Full Text] [Related]
10. Investigation of intratumoural and peritumoural lymphatics expressed by podoplanin and LYVE-1 in the hybridoma-induced tumours.
Ji RC; Eshita Y; Kato S
Int J Exp Pathol; 2007 Aug; 88(4):257-70. PubMed ID: 17696907
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
Li YS; Kaneko M; Amatya VJ; Takeshima Y; Arihiro K; Inai K
Pathol Int; 2006 May; 56(5):256-61. PubMed ID: 16669874
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
Wobser M; Siedel C; Schrama D; Bröcker EB; Becker JC; Vetter-Kauczok CS
Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
[TBL] [Abstract][Full Text] [Related]
13. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
[TBL] [Abstract][Full Text] [Related]
16. The role of the VEGF-C/VEGFR-3 axis in cancer progression.
Su JL; Yen CJ; Chen PS; Chuang SE; Hong CC; Kuo IH; Chen HY; Hung MC; Kuo ML
Br J Cancer; 2007 Feb; 96(4):541-5. PubMed ID: 17164762
[TBL] [Abstract][Full Text] [Related]
17. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
Schneider M; Büchler P; Giese N; Giese T; Wilting J; Büchler MW; Friess H
Int J Oncol; 2006 Apr; 28(4):883-90. PubMed ID: 16525637
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factors VEGF- C and D, VEGFR-3, and comparison of lymphatic vessels density labeled with D2-40 antibodies as a prognostic factors in vulvar intraepithelial neoplasia (VIN) and invasive vulvar cancer.
Jach R; Dyduch G; Radon-Pokracka M; Przybylska P; Mika M; Dulinska-Litewka J; Zajac K; Huras H; Streb J; Stangel-Wojcikiewicz K; Dziadek O; Galarowicz B
Neuro Endocrinol Lett; 2011; 32(4):530-9. PubMed ID: 21876509
[TBL] [Abstract][Full Text] [Related]
19. Lymphangiogenesis in gastric carcinoma correlates with prognosis.
Gao P; Zhou GY; Zhang QH; Su ZX; Zhang TG; Xiang L; Wang Y; Zhang SL; Mu K
J Pathol; 2009 Jun; 218(2):192-200. PubMed ID: 19224540
[TBL] [Abstract][Full Text] [Related]
20. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]